SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: JEB who wrote (80718)6/26/1999 9:36:00 AM
From: Bruce Bland  Read Replies (1) | Respond to of 119973
 
To all: As some have suggested the next sector of strength to be bio-meds, and particularly cancer research, I offer NERX for your scrutiny. Home page (read most recent NR: neorx.com
I have held a small position since the most recent NR, and have observed buyers coming in consistently at the 1 1/2-1 9/16 levels. IMO, there is little risk here, however, despite the tight spread the volume has remained low. I am holding this as a position/long for personal reasons, but will not hesitate to daytrade should it become volatile. I am impressed with management and their commitment to their goals, and the fundamentals compared to similar companies in the sector. TA offers an excellent opportunity to determine entrance and exit: iqc.com

NeoRx Corporation Ticker: NERX Page 1 of 10
Complete Financials: March 1999 Exchange NASD
FY END DEC
ISSUE DATA (06/18/99) PER SHARE DATA RATIOS
Price $ 1.69 EPS (TTM) $ -0.60 P/E (TTM) NM
52W High $ 5.56 Div. Rate $ 0.00 Yield 0.00 %
52W Low $ 0.97 Book Value $ 1.25 Price/Book 1.35
Shrs Out 21.01 Mil Cash $ 1.29 ROE (TTM) -38.92 %
Float 14.30 Mil Rev (TTM) $ 0.09 ROA (TTM) -34.09 %
Mon. Vol 1.83 Mil Curr. Ratio 15.31
Beta 0.75 LT Dbt/Eqty 0.05
Bruce